Suppr超能文献

干眼症患者新型自身抗体的临床相关性。

Clinical Correlations of Novel Autoantibodies in Patients with Dry Eye.

机构信息

Ocular Surface Diseases and Dry Eye Clinic, The Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, USA.

The Johns Hopkins Jerome L. Greene Sjögren's Syndrome Center, Baltimore, MD, USA.

出版信息

J Immunol Res. 2019 Jan 13;2019:7935451. doi: 10.1155/2019/7935451. eCollection 2019.

Abstract

BACKGROUND

Diagnostic criteria for Sjögren's syndrome (SS) are continually being updated in pursuit of more precise and earlier diagnosis to prevent its complications. Owing to the high rate of false negative traditional serological markers, the need for better serological testing remains.

OBJECTIVE

To investigate the clinical significance of three recently discovered novel autoantibodies, anti-salivary gland protein 1 (SP1), anti-carbonic anhydrase 6 (CA6), and anti-parotid secretory protein (PSP), in a cohort of dry eye patients with suspected underlying inflammatory/autoimmune disease.

METHODS

Medical records of 136 patients with a primary diagnosis of dry eye who underwent laboratory testing between April 2014 and July 2017 were reviewed retrospectively. Data regarding demographic information, ocular and systemic symptoms, previous medical diagnoses, serological test results, and minor salivary gland biopsy results were collected. Dry eye evaluations included tear osmolarity, Schirmer test without anesthesia, conjunctival lissamine green staining, and corneal fluorescein staining in the order listed here.

RESULTS

Of the 136 patients, 9 (9/136, 6.6%) presented with a history of SS, and 9 additional patients (9/127, 7%) received a new diagnosis of SS as a result of evaluations. Fifty-six patients (56/136, 41%) tested positive for at least one of the novel autoantibodies. Fifty-four percent (6/11) of patients with primary SS who underwent the novel serological testing had a positive anti-PSP. Of those, 2 (2/11, 18%) had negative traditional serology and had to undergo minor salivary gland biopsy for definitive diagnosis. Anti-CA6 was associated with increased corneal and conjunctival staining after adjusting for age, sex, and other serologic markers (HR = 1.5, 95% CI = 1.20-1.97, and = 0.009 and HR = 1.4, 95% CI = 1.04-1.76, and = 0.02, respectively).

CONCLUSIONS

This cross-sectional study demonstrated that anti-CA6 is seen in patients with severe aqueous-deficient dry eye. Whether these patients have an early stage of SS or a different type of autoimmune condition may be determined through longitudinal studies.

摘要

背景

干燥综合征(SS)的诊断标准在不断更新,旨在更精确、更早地诊断疾病,以预防其并发症。由于传统血清学标志物的假阴性率较高,因此仍需要更好的血清学检测。

目的

探讨三种新发现的自身抗体(抗唾液腺蛋白 1(SP1)、抗碳酸酐酶 6(CA6)和抗腮腺分泌蛋白(PSP))在疑似潜在炎症/自身免疫性疾病的干眼患者中的临床意义。

方法

回顾性分析 2014 年 4 月至 2017 年 7 月间进行实验室检查的 136 例原发性干眼患者的病历。收集人口统计学信息、眼部和全身症状、既往诊断、血清学检查结果和小唾液腺活检结果。干眼评估包括泪液渗透压、无麻醉情况下的 Schirmer 试验、结膜丽丝胺绿染色和角膜荧光素染色,按此顺序进行。

结果

在 136 例患者中,9 例(9/136,6.6%)有 SS 病史,9 例(9/127,7%)因评估新诊断为 SS。56 例(56/136,41%)至少有一种新型自身抗体阳性。在接受新型血清学检测的原发性 SS 患者中,6 例(6/11,54%)抗 PSP 阳性。其中,2 例(2/11,18%)传统血清学检查阴性,需进行小唾液腺活检以明确诊断。校正年龄、性别和其他血清学标志物后,抗 CA6 与角膜和结膜染色增加相关(HR=1.5,95%CI=1.20-1.97,P=0.009 和 HR=1.4,95%CI=1.04-1.76,P=0.02)。

结论

本横断面研究表明,抗 CA6 可见于严重水样液缺乏性干眼患者中。这些患者是处于 SS 的早期阶段,还是存在其他自身免疫性疾病,可能需要通过纵向研究来确定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c4/6350592/11ae7ef81ecf/JIR2019-7935451.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验